特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
648632

遺伝子検査の世界市場:産業分析、地域展望、アプリケーション可能性、競合市場シェア、予測

Genetic Testing Market Size By Test Type, By Application, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 - 2025

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 140 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.89円
遺伝子検査の世界市場:産業分析、地域展望、アプリケーション可能性、競合市場シェア、予測
出版日: 2019年08月27日
発行: Global Market Insights Inc.
ページ情報: 英文 140 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の遺伝子検査市場について分析し、産業の基本構造、規制環境、技術情勢、主な市場促進・抑制要因、検査タイプ・アプリケーション・地域別の市場動向見通し、主要企業のプロファイルなど、体系的な情報を提供しています。

第1章 分析手法・範囲

第2章 エグゼクティブサマリー

第3章 遺伝子検査:産業分析

  • 産業区分
  • 産業情勢
  • 産業の影響要因
  • 規制情勢
  • 成長可能性の分析
  • ポーターのファイブフォース分析
  • 競合情勢
  • PESTEL分析

第4章 遺伝子検査市場:検査タイプ別

  • 主なセグメントの動向
  • 予測検査
  • 保因者検査
  • 出生前・新生児検査
  • 診断検査
  • 薬理ゲノミクス検査
  • その他

第5章 遺伝子検査市場:アプリケーション別

  • 主なセグメントの動向
  • 癌診断
  • 遺伝子疾患診断
  • 心血管疾患診断
  • その他

第6章 遺伝子検査市場:地域別

  • 主要地域の動向
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第7章 企業プロファイル

  • 23andMe
  • Abbott Molecular
  • Bayer Diagnostics
  • Biocartis
  • BioHelix
  • BioMerieux
  • BGI
  • Celera Genomics
  • Cepheid
  • Counsyl
  • deCODEme
  • Genentech
  • Genomictree
  • Genomic Health
  • HTG Molecular Diagnostics
  • IntegraGen
  • LabCorp Diagnostics
  • Luminex
  • MolecularMD
  • Myriad
  • Natera
  • PacBio
  • Pathway Genomics
  • Qiagen
  • Roche Diagnostics
  • Sequenom
  • Siemens
図表

Data Tables

  • TABLE 1. Genetic testing industry 360 degree synopsis, 2014 - 2025
  • TABLE 2. Global genetic testing market, 2014 - 2025 (USD Million)
  • TABLE 3. Genetic testing market, by test type, 2014 - 2025 (USD Million)
  • TABLE 4. Genetic testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 5. Genetic testing market, by region, 2014 - 2025 (USD Million)
  • TABLE 6. Predictive testing market by region, 2014 - 2025 (USD Million)
  • TABLE 7. Carrier testing market by region, 2014 - 2025 (USD Million)
  • TABLE 8. Prenatal and newborn testing market by region, 2014 - 2025 (USD Million)
  • TABLE 9. Diagnostic testing market, by region, 2014 - 2025, ( USDMillion)
  • TABLE 10. Pharmacogenomic testing market, by region, 2014 - 2025, (USD Million)
  • TABLE 11. Nutrigenomics testing market, by region, 2014 - 2025, (USD Million)
  • TABLE 12. Others market by region, 2014 - 2025 (USD Million)
  • TABLE 13. Cancer market by region, 2014 - 2025 (USD Million)
  • TABLE 14. Genetic diseases market by region, 2014 - 2025 (USD Million)
  • TABLE 15. Cardiovascular diseases market by region, 2014 - 2025 (USD Million)
  • TABLE 16. Others market by region, 2014 - 2025 (USD Million)
  • TABLE 17. North America genetic testing market, by country, 2014 - 2025 (USD Million)
  • TABLE 18. North America genetic testing market, by test type, 2014 - 2025 (USD Million)
  • TABLE 19. North America genetic testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 20. U.S. genetic testing market, by test type, 2014 - 2025 (USD Million)
  • TABLE 21. U.S. genetic testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 22. Canada genetic testing market, by test type, 2014 - 2025 (USD Million)
  • TABLE 23. Canada genetic testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 24. Europe genetic testing market, by country, 2014 - 2025 (USD Million)
  • TABLE 25. Europe genetic testing market, by test type, 2014 - 2025 (USD Million)
  • TABLE 26. Europe genetic testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 27. Germany genetic testing market, by test type, 2014 - 2025 (USD Million)
  • TABLE 28. Germany genetic testing market, by application, 2014 - 2025 (USD Milion)
  • TABLE 29. UK genetic testing market, by test type, 2014 - 2025 (USD Million)
  • TABLE 30. UK genetic testing market, by application, 2014 - 2025 (USD Milion)
  • TABLE 31. France genetic testing market, by test type, 2014 - 2025 (USD Million)
  • TABLE 32. France genetic testing market, by application, 2014 - 2025 (USD Milion)
  • TABLE 33. Spain genetic testing market, by test type, 2014 - 2025 (USD Million)
  • TABLE 34. Spain genetic testing market, by application, 2014 - 2025 (USD Milion)
  • TABLE 35. Italy genetic testing market, by test type, 2014 - 2025 (USD Million)
  • TABLE 36. Italy genetic testing market, by application, 2014 - 2025 (USD Milion)
  • TABLE 37. Russia genetic testing market, by test type, 2014 - 2025 (USD Million)
  • TABLE 38. Russia genetic testing market, by application, 2014 - 2025 (USD Milion)
  • TABLE 39. Asia Pacific genetic testing market, by country, 2014 - 2025 (USD Million)
  • TABLE 40. Asia Pacific genetic testing market, by test type, 2014 - 2025 (USD Million)
  • TABLE 41. Asia Pacific genetic testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 42. Japan genetic testing market, by test type, 2014 - 2025 (USD Million)
  • TABLE 43. Japan genetic testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 44. China genetic testing market, by test type, 2014 - 2025 (USD Million)
  • TABLE 45. China genetic testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 46. India genetic testing market, by test type, 2014 - 2025 (USD Million)
  • TABLE 47. India genetic testing market, by test type, 2014 - 2025 (USD Million)
  • TABLE 48. Australia genetic testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 49. Australia genetic testing market, by test type, 2014 - 2025 (USD Million)
  • TABLE 50. South Korea genetic testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 51. South Korea genetic testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 52. Latin America genetic testing market, by country, 2014 - 2025 (USD Million)
  • TABLE 53. Latin America genetic testing market, by test type, 2014 - 2025 (USD Million)
  • TABLE 54. Latin America genetic testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 55. Brazil genetic testing market, by test type, 2014 - 2025 (USD Million)
  • TABLE 56. Brazil genetic testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 57. Argentina genetic testing market, by test type, 2014 - 2025 (USD Million)
  • TABLE 58. Argentina genetic testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 59. Mexico genetic testing market, by test type, 2014 - 2025 (USD Million)
  • TABLE 60. Mexico genetic testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 61. MEA genetic testing market, by country, 2014 - 2025 (USD Million)
  • TABLE 62. MEA genetic testing market, by test type, 2014 - 2025 (USD Million)
  • TABLE 63. MEA genetic testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 64. South Africa genetic testing market, by test type, 2014 - 2025 (USD Million)
  • TABLE 65. South Africa genetic testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 66. Saudi Arabia genetic testing market, by test type, 2014 - 2025 (USD Million)
  • TABLE 67. Saudi Arabia genetic testing market, by application, 2014 - 2025 (USD Million)
  • TABLE 68. UAE genetic testing market, by test type, 2014 - 2025 (USD Million)
  • TABLE 69. UAE genetic testing market, by application, 2014 - 2025 (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Genetic testing market, 2014 - 2025 (USD Million)
  • FIG. 3 Growth potential analysis, By Test type
  • FIG. 4 Growth potential analysis, By Application
  • FIG. 5 Porter's analysis
  • FIG. 6 Competitive Landscape
  • FIG. 7 Strategy Dashboard
  • FIG. 8 PESTEL Analysis
目次
Product Code: 2490

Title:
Genetic Testing Market Size By Test Type (Predictive Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Nutrigenomic Testing), By Application (Cancer, Genetic Disease, Cardiovascular Disease), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 - 2025.

Genetic Testing Market will reach USD 22.5 billion by 2024; as per a new research report.

Increasing prevalence of cancer and other genetic diseases worldwide will drive industry growth over the forecast timeframe. Breast cancer is the second leading cause of cancer deaths among women. According to the Pan American Health Organization (PAHO), around 4,08,200 breast cancer cases and 92,000 cancer deaths were recorded in 2013. The number of breast cancer cases in Americas is expected to grow by 46% by 2030. Furthermore, increasing awareness among patients pertaining to early detection of diseases helps patients to undergo timely treatment and minimize the risks associated with the diseases. Aforementioned factors are expected to fuel the demand for genetic testing thereby propelling the market growth.

Availability of new tests owing to technological advancements in the field of genetic testing will serve to be high impact rendering factor. Demand for genetic testing is increasing due to the development of non-invasive tests that can be used in detection of genetic abnormalities during early pregnancy. Availability of highly sensitive and efficient tests for early diagnosis of diseases will boost the market growth. Moreover, increasing consumer demand for personalized medicines based on molecular basis of the diseases will further drive the genetic testing market during the forthcoming years.

However, dearth of experienced professionals and lack of advanced infrastructure in developing region will impede the industry growth. Furthermore, high costs involved in genetic testing will hamper the growth of genetic testing market.

Diagnostic testing dominated the genetic testing market and accounted for USD 5,690.6 million in 2017. It is expected to witness robust growth during the forecast period attributable to the increasing prevalence of chronic diseases worldwide. Diagnostic testing enables early diagnosis of diseases allowing patients to undergo timely therapeutic treatment, lower the severity of diseases and reduce the mortality rate.

Cardiovascular disease diagnosis segment is expected to grow at the fastest rate during the forthcoming years. Cardiac diseases are the leading cause of deaths worldwide and are caused by a combination of genetic and environmental factors. The onset and treatment of CVDs can be controlled if it is diagnosed prior to manifestation of actual disease in patients with high risk of developing a CVD. Genetic testing helps to reliably determine an individual's risk to develop CVDs based on their genetic data using preventive genetic screening.

U.S. genetic testing market dominated the industry owing to increasing prevalence of chronic diseases, developed healthcare facilities and technological advancements. Rising prevalence of genetic diseases such as cancer, cardiac disease, neurofibromatosis, cystic fibrosis, Turner syndrome and spinal muscular atrophy will augment the market growth. Moreover, increasing insurance coverage and regulatory support for direct to consumer (DTC) genetic testing coupled with reduction in the cost of genetic tests is expected to propel the demand for genetic testing in the U.S. over the forecast period.

Some of the notable industry players operating in global genetic testing market are 23andMe, Abbott Molecular, Bayer Diagnostics, Biocartis, BioHelix, BioMerieux, BGI, Celera Genomics, Cepheid, Counsyl, deCODEme, Genentech, Genomictree, Genomic Health, HTG Molecular Diagnostics, IntegraGen, LabCorp Diagnostics, Luminex, MolecularMD, Myriad, Natera, PacBio, Pathway Genomics, Qiagen, Roche Diagnostics, Sequenom and Siemens.

Major industry players are primarily focusing on acquisitions and collaborations as their key strategies. They are increasing their emphasis on enhancing and strengthening the product portfolio to enhance their existing systems.

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
  • 1.2. Market definition
  • 1.3. Forecast parameters
  • 1.4. Data sources
    • 1.4.1. Secondary
      • 1.4.1.1. Paid sources
      • 1.4.1.2. Unpaid sources
    • 1.4.2. Primary

Chapter 2. Executive Summary

  • 2.1. Genetic testing industry 36 degree synopsis, 2014 - 2025
    • 2.1.1. Business trends
    • 2.1.2. Test type trends
    • 2.1.3. Application trends
    • 2.1.4. Regional trends

Chapter 3. Genetic Testing Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2014 - 2025
  • 3.3. Industry impact forces
    • 3.3.1. Growth drivers
      • 3.3.1.1. Growing application of genetic testing in oncology and genetic diseases in North America
      • 3.3.1.2. Technological advancement and availability of new tests
      • 3.3.1.3. Consumer interest in personalized medicine in Europe
      • 3.3.1.4. Physician adoption of genetic tests into clinical care
      • 3.3.1.5. Growing demand for direct-to-consumer genetic testing
    • 3.3.2. Industry pitfalls & challenges
      • 3.3.2.1. High cost of genetic testing
      • 3.3.2.2. Dearth of experienced professionals in developing and underdeveloped countries
  • 3.4. Regulatory landscape
    • 3.4.1. U.S.
    • 3.4.2. Europe
  • 3.5. Growth potential analysis
    • 3.5.1. By test type
    • 3.5.2. By application
  • 3.6. Porter's analysis
  • 3.7. Competitive landscape, 2017
    • 3.7.1. Strategy dashboard
  • 3.8. PESTEL analysis

Chapter 4. Genetic Testing Market, By Test Type

  • 4.1. Key segment trends
  • 4.2. Predictive testing
    • 4.2.1. Market size, by region, 2014-2025 (USD Million)
  • 4.3. Carrier testing
    • 4.3.1. Market size, by region, 2014-2025 (USD Million)
  • 4.4. Prenatal and newborn testing
    • 4.4.1. Market size, by region, 2014-2025 (USD Million)
  • 4.5. Diagnostic testing
    • 4.5.1. Market size, by region, 2014-2025 (USD Million)
  • 4.6. Pharmacogenomic testing
    • 4.6.1. Market size, by region, 2014-2025 (USD Million)
  • 4.7. Nutrigenomic Testing
    • 4.7.1. Market size, by region, 2014-2025 (USD Million)
  • 4.8. Others
    • 4.8.1. Market size, by region, 2014-2025 (USD Million)

Chapter 5. Genetic Testing Market, By Application

  • 5.1. Key segment trends
  • 5.2. Cancer
    • 5.2.1. Market size, by region, 2014-2025 (USD Million)
  • 5.3. Genetic diseases
    • 5.3.1. Market size, by region, 2014-2025 (USD Million)
  • 5.4. Cardiovascular diseases
    • 5.4.1. Market size, by region, 2014-2025 (USD Million)
  • 5.5. Others
    • 5.5.1. Market size, by region, 2014-2025 (USD Million)

Chapter 6. Genetic Testing Market, By Region

  • 6.1. Key regional trends
  • 6.2. North America
    • 6.2.1. Market size, by country, 2014-2025 (USD Million)
    • 6.2.2. Market size, by test type, 2014-2025 (USD Million)
    • 6.2.3. Market size, by application, 2014-2025 (USD Million)
    • 6.2.4. U.S.
      • 6.2.4.1. Market size, by test type, 2014-2025 (USD Million)
      • 6.2.4.2. Market size, by application, 2014-2025 (USD Million)
    • 6.2.5. Canada
      • 6.2.5.1. Market size, by test type, 2014-2025 (USD Million)
      • 6.2.5.2. Market size, by application, 2014-2025 (USD Million)
  • 6.3. Europe
    • 6.3.1. Market size, by country, 2014-2025 (USD Million)
    • 6.3.2. Market size, by test type, 2014-2025 (USD Million)
    • 6.3.3. Market size, by application, 2014-2025 (USD Million)
    • 6.3.4. Germany
      • 6.3.4.1. Market size, by test type, 2014-2025 (USD Million)
      • 6.3.4.2. Market size, by application, 2014-2025 (USD Million)
    • 6.3.5. UK
      • 6.3.5.1. Market size, by test type, 2014-2025 (USD Million)
      • 6.3.5.2. Market size, by application, 2014-2025 (USD Million)
    • 6.3.6. France
      • 6.3.6.1. Market size, by test type, 2014-2025 (USD Million)
      • 6.3.6.2. Market size, by application, 2014-2025 (USD Million)
    • 6.3.7. Spain
      • 6.3.7.1. Market size, by test type, 2014-2025 (USD Million)
      • 6.3.7.2. Market size, by application, 2014-2025 (USD Million)
    • 6.3.8. Italy
      • 6.3.8.1. Market size, by test type, 2014-2025 (USD Million)
      • 6.3.8.2. Market size, by application, 2014-2025 (USD Million)
    • 6.3.9. Russia
      • 6.3.9.1. Market size, by test type, 2014-2025 (USD Million)
      • 6.3.9.2. Market size, by application, 2014-2025 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Market size, by country, 2014-2025 (USD Million)
    • 6.4.2. Market size, by test type, 2014-2025 (USD Million)
    • 6.4.3. Market size, by application, 2014-2025 (USD Million)
    • 6.4.4. Japan
      • 6.4.4.1. Market size, by test type, 2014-2025 (USD Million)
      • 6.4.4.2. Market size, by application, 2014-2025 (USD Million)
    • 6.4.5. China
      • 6.4.5.1. Market size, by test type, 2014-2025 (USD Million)
      • 6.4.5.2. Market size, by application, 2014-2025 (USD Million)
    • 6.4.6. India
      • 6.4.6.1. Market size, by test type, 2014-2025 (USD Million)
      • 6.4.6.2. Market size, by application, 2014-2025 (USD Million)
    • 6.4.7. Australia
      • 6.4.7.1. Market size, by test type, 2014-2025 (USD Million)
      • 6.4.7.2. Market size, by application, 2014-2025 (USD Million)
    • 6.4.8. South Korea
      • 6.4.8.1. Market size, by test type, 2014-2025 (USD Million)
      • 6.4.8.2. Market size, by application, 2014-2025 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Market size, by country, 2014-2025 (USD Million)
    • 6.5.2. Market size, by test type, 2014-2025 (USD Million)
    • 6.5.3. Market size, by application, 2014-2025 (USD Million)
    • 6.5.4. Brazil
      • 6.5.4.1. Market size, by test type, 2014-2025 (USD Million)
      • 6.5.4.2. Market size, by application, 2014-2025 (USD Million)
    • 6.5.5. Argentina
      • 6.5.5.1. Market size, by test type, 2014-2025 (USD Million)
      • 6.5.5.2. Market size, by application, 2014-2025 (USD Million)
    • 6.5.6. Mexico
      • 6.5.6.1. Market size, by test type, 2014-2025 (USD Million)
      • 6.5.6.2. Market size, by application, 2014-2025 (USD Million)
  • 6.6. MEA
    • 6.6.1. Market size, by country, 2014-2025 (USD Million)
    • 6.6.2. Market size, by test type, 2014-2025 (USD Million)
    • 6.6.3. Market size, by application, 2014-2025 (USD Million)
    • 6.6.4. South Africa
      • 6.6.4.1. Market size, by test type, 2014-2025 (USD Million)
      • 6.6.4.2. Market size, by application, 2014-2025 (USD Million)
    • 6.6.5. Saudi Arabia
      • 6.6.5.1. Market size, by test type, 2014-2025 (USD Million)
      • 6.6.5.2. Market size, by application, 2014-2025 (USD Million)
    • 6.6.6. UAE
      • 6.6.6.1. Market size, by test type, 2014-2025 (USD Million)
      • 6.6.6.2. Market size, by application, 2014-2025 (USD Million)

Chapter 7. Company Profiles

  • 7.1. 23andMe
    • 7.1.1. Business overview
    • 7.1.2. Financial data
    • 7.1.3. Product landscape
    • 7.1.4. Strategic outlook
    • 7.1.5. SWOT analysis
  • 7.2. Abbott Molecular
    • 7.2.1. Business overview
    • 7.2.2. Financial data
    • 7.2.3. Product landscape
    • 7.2.4. Strategic outlook
    • 7.2.5. SWOT analysis
  • 7.3. Bayer Diagnostics
    • 7.3.1. Business overview
    • 7.3.2. Financial data
    • 7.3.3. Product landscape
    • 7.3.4. Strategic outlook
    • 7.3.5. SWOT analysis
  • 7.4. Biocartis
    • 7.4.1. Business overview
    • 7.4.2. Financial data
    • 7.4.3. Product landscape
    • 7.4.4. Strategic outlook
    • 7.4.5. SWOT analysis
  • 7.5. BioHelix
    • 7.5.1. Business overview
    • 7.5.2. Financial data
    • 7.5.3. Product landscape
    • 7.5.4. Strategic outlook
    • 7.5.5. SWOT analysis
  • 7.6. BioMerieux
    • 7.6.1. Business overview
    • 7.6.2. Financial data
    • 7.6.3. Product landscape
    • 7.6.4. Strategic outlook
    • 7.6.5. SWOT analysis
  • 7.7. BGI
    • 7.7.1. Business overview
    • 7.7.2. Financial data
    • 7.7.3. Product landscape
    • 7.7.4. Strategic outlook
    • 7.7.5. SWOT analysis
  • 7.8. Celera Genomics
    • 7.8.1. Business overview
    • 7.8.2. Financial data
    • 7.8.3. Product landscape
    • 7.8.4. Strategic outlook
    • 7.8.5. SWOT analysis
  • 7.9. Cepheid
    • 7.9.1. Business overview
    • 7.9.2. Financial data
    • 7.9.3. Product landscape
    • 7.9.4. Strategic outlook
    • 7.9.5. SWOT analysis
  • 7.10. Counsyl
    • 7.10.1. Business overview
    • 7.10.2. Financial data
    • 7.10.3. Product landscape
    • 7.10.4. Strategic outlook
    • 7.10.5. SWOT analysis
  • 7.11. deCODEme
    • 7.11.1. Business overview
    • 7.11.2. Financial data
    • 7.11.3. Product landscape
    • 7.11.4. Strategic outlook
    • 7.11.5. SWOT analysis
  • 7.12. Genentech
    • 7.12.1. Business overview
    • 7.12.2. Financial data
    • 7.12.3. Product landscape
    • 7.12.4. Strategic outlook
    • 7.12.5. SWOT analysis
  • 7.13. Genomictree
    • 7.13.1. Business overview
    • 7.13.2. Financial data
    • 7.13.3. Product landscape
    • 7.13.4. Strategic outlook
    • 7.13.5. SWOT analysis
  • 7.14. Genomic Health
    • 7.14.1. Business overview
    • 7.14.2. Financial data
    • 7.14.3. Product landscape
    • 7.14.4. Strategic outlook
    • 7.14.5. SWOT analysis
  • 7.15. HTG Molecular Diagnostics
    • 7.15.1. Business overview
    • 7.15.2. Financial data
    • 7.15.3. Product landscape
    • 7.15.4. Strategic outlook
    • 7.15.5. SWOT analysis
  • 7.16. IntegraGen
    • 7.16.1. Business overview
    • 7.16.2. Financial data
    • 7.16.3. Product landscape
    • 7.16.4. Strategic outlook
    • 7.16.5. SWOT analysis
  • 7.17. LabCorp Diagnostics
    • 7.17.1. Business overview
    • 7.17.2. Financial data
    • 7.17.3. Product landscape
    • 7.17.4. Strategic outlook
    • 7.17.5. SWOT analysis
  • 7.18. Luminex
    • 7.18.1. Business overview
    • 7.18.2. Financial data
    • 7.18.3. Product landscape
    • 7.18.4. Strategic outlook
    • 7.18.5. SWOT analysis
  • 7.19. MolecularMD
    • 7.19.1. Business overview
    • 7.19.2. Financial data
    • 7.19.3. Product landscape
    • 7.19.4. Strategic outlook
    • 7.19.5. SWOT analysis
  • 7.20. Myriad
    • 7.20.1. Business overview
    • 7.20.2. Financial data
    • 7.20.3. Product landscape
    • 7.20.4. Strategic outlook
    • 7.20.5. SWOT analysis
  • 7.21. Natera
    • 7.21.1. Business overview
    • 7.21.2. Financial data
    • 7.21.3. Product landscape
    • 7.21.4. Strategic outlook
    • 7.21.5. SWOT analysis
  • 7.22. PacBio
    • 7.22.1. Business overview
    • 7.22.2. Financial data
    • 7.22.3. Product landscape
    • 7.22.4. Strategic outlook
    • 7.22.5. SWOT analysis
  • 7.23. Pathway Genomics
    • 7.23.1. Business overview
    • 7.23.2. Financial data
    • 7.23.3. Product landscape
    • 7.23.4. Strategic outlook
    • 7.23.5. SWOT analysis
  • 7.24. Qiagen
    • 7.24.1. Business overview
    • 7.24.2. Financial data
    • 7.24.3. Product landscape
    • 7.24.4. Strategic outlook
    • 7.24.5. SWOT analysis
  • 7.25. Roche Diagnostics
    • 7.25.1. Business overview
    • 7.25.2. Financial data
    • 7.25.3. Product landscape
    • 7.25.4. Strategic outlook
    • 7.25.5. SWOT analysis
  • 7.26. Sequenom
    • 7.26.1. Business overview
    • 7.26.2. Financial data
    • 7.26.3. Product landscape
    • 7.26.4. Strategic outlook
    • 7.26.5. SWOT analysis
  • 7.27. Siemens
    • 7.27.1. Business overview
    • 7.27.2. Financial data
    • 7.27.3. Product landscape
    • 7.27.4. Strategic outlook
    • 7.27.5. SWOT analysis
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.